Table 2 Recommended treatment targets
From: A systematic review of guidelines for managing rheumatoid arthritis
Guideline | Treatment Target | Remission Definitions | Treat Moderate Disease | |||||
|---|---|---|---|---|---|---|---|---|
Remission | LDA | Suppress Inflammation | ||||||
1. American [14] | Yes | Yes | – | SDAI | Boolean |  |  | Yes |
2. APLAR [15] | Yes | Yes | – | DAS28 | SDAI | CDAI | Boolean | Yes |
3. Australian [16] | Yes | – | – | – | – | – | – | Yes |
4. Brazilian [17] | Yes | Yes |  | DAS28 | SDAI | CDAI | – | Yes |
5. British Columbia [18] | – | – | Yes | – | – | – | – | – |
6. British Society For Rheumatology: Established [19] | Yes | – | Yes | – | – | – | – | – |
7. British Society For Rheumatology: Early [20] | – | – | – | – | – | – | – | – |
8. Canadian [21] | Yes | Yes | – | DAS28 | SDAI | CDAI | Boolean | Yes |
9. EULAR [22] | Yes | Yes | – | SDAI | Boolean | – | – | Yesa |
10. French [23] | Yes | Yes | – | DAS28 | SDAI | CDAI | Boolean | Yes |
11. German [24] | Yes | Yes | – | DAS28 | – | – | – | Yesa |
12. Hong Kong [25] | Yes | – | – | DAS28 | – | – | – | Yesa |
13. Indian [26] | Yes | – | – | – | – | – | – | Yes |
14. Latin American [27] | Yes | Yes | – | DAS28 | – | – | – | – |
15. Mexican [28] | Yes | Yes | – | DAS28 | – | – | – | Yes |
16. England [29] | Yes | Yes | – | DAS28 | – | – | – | – |
17. Scotland [30] | Yes | Yes | – | DAS28 | – | – | – | Yes |
18. South African [31] | Yes | Yes | – | SDAI | – | – | – | Yes |
19. Spanish [32] | Yes | Yes | – | DAS28 | CDAI | Boolean | – | Yesa |
20. Swedish [33] | Yes | Yes | – | DAS28 | SDAI | CDAI | – | Yes |
21. Treat to Target [34] | Yes | Yes | – | DAS28 | SDAI | CDAI | Boolean | Yes |
22. Turkish [35] | Yes | Yes | – | – | – | – | – | Yes |